PTC Therapeutics(PTCT.US)盘前涨超10%
PTC Therapeutics(US:PTCT) Ge Long Hui A P P·2025-07-29 09:58Core Insights - PTC Therapeutics' metabolic disease treatment drug received FDA approval, leading to a pre-market stock price increase of over 10% [1] - Barclays Bank raised its target price for PTC Therapeutics to $46 [1]